Sunovion Strengthens its Respiratory Portfolio by Acquiring Elevation Pharmaceuticals
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 9 (Table of Contents)
Published: 11 Sep-2012
DOI: 10.3833/pdr.v2012.i9.1804 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Sunovion Pharmaceuticals has bought Elevation Pharmaceuticals, which specialises in the development of aerosol therapies for patients with respiratory diseases, in a deal potentially worth US$430 M including US$100 M upfront...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS